Welcome to The Stem Cell Show!!!
Stem cells remain a fascination to the general public – and to the medical profession as well!
While millions of dollars are being spent by most States each year on stem cell research, and while the National Institute of Health (NIH) spends $1 Billion dollars per year on stem cell research, both the lay public and medical professionals continue to wonder: Where are we? How much have we learned? Are we making progress introducing stem cell therapy to the public?
As your host of The Stem Cell Show, we will explore the many facets, intrigue and complexities of stem cells and stem cell therapy.
We will have a frank and open discussion on the type of progress we are making in advancing stem cell biology and therapy from the bench to the bedside. We will explore the current law regarding stem cell practice; both state law and federal law. We will also investigate how new therapies – like stem cell therapies – get “approved” – and the role of the FDA, an IRB, and the role of the US Department of Health, Office of Human Research Protections (OHRP) in the provision of such “approval.”
We will, of course, explore the different types of stem cells with respect to their potential uses. And, we will look at new and emerging stem cell therapies which are being considered to address various medical infirmities such as Emphysema, COPD, Asthma, Heart Failure, Heart Attack, Parkinson’s Disease, Stroke, Traumatic Brain Injury, Lou Gehrig’s Disease, Multiple Sclerosis, Lupus, Rheumatoid Arthritis, Crohn’s Disease, Muscular Dystrophy, Inflammatory Myopathies, and degenerative orthopedic joint conditions (Knee, Shoulder, Hip, Spine).
The format of The Stem Cell Show will be Questions and Answers, as well as Interviews of key thought leaders and researchers currently engaged in stem cell therapy – both nationally and internationally.
The spirit of The Stem Cell Show will be that of honest, open and vibrant discussion – in an effort to advance the public’s health, well being, and the amelioration of devastating chronic disease.
Thomas A. Gionis, MD JD MPH MBA MHA LLM FAIHQ
Surgeon-in-Chief, Irvine Stem Cell Treatment Center
Surgeon-in-Chief, Miami Stem Cell Treatment Center
Surgeon-in-Chief, Manhattan Regenerative Medicine Medical Group
United States Fulbright Scholar in Law
United States Fulbright PEER Review Committee Member Global / Public Health
President & Chairman of the Board, American Board of Stem Cell Medicine and Surgery
President & Chairman of the Board, Fulbright Academy of Law, Peace and Public Health
Board Certified, American Board of Quality Assurance and Utilization Review Physicians
The Hague Academy of International Law, Advanced Certificate in International Law
Fellow, American Institute for Healthcare Quality